Gennex Laboratories has announced a special, time-limited opportunity for shareholders to resubmit previously rejected requests for physical share transfers.

This initiative addresses past rejections that occurred due to reasons like signature mismatches or other procedural issues, ensuring that upon successful processing, shares are credited only in dematerialized form.

This is a crucial step for affected investors, allowing them to convert their physical holdings into a convenient and modern electronic format for easier management and trading.